NGNE Competitors & Alternatives
Compare Neurogene, Inc. Common Stock with similar stocks in the same industry
PHARMACEUTICAL PREPARATIONS
NGNE
Main Stock$20.69
Tradestie Score
51
Market Cap
$256.54M
Analyst Upside
+291.5%
Top Competitors
553 stocks in PHARMACEUTICAL PREPARATIONS| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$935.58
|
$739.95B | 41.7 | 57 | Compare |
|
JNJ
Johnson & Johnson
|
$243.04
|
$448.07B | 22.1 | 64 | Compare |
|
ABBV
ABBVIE INC.
|
$208.84
|
$431.71B | 91.1 | 59 | Compare |
|
NVO
Novo-Nordisk A/S
|
$36.98
|
$262.92B | 10.2 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$203.49
|
$261.56B | 30.7 | 56 | Compare |
|
NVS
Novartis AG
|
$154.03
|
$254.99B | 21.7 | 59 | Compare |
|
ABT
Abbott Laboratories
|
$102.87
|
$232.30B | 27.5 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.87
|
$225.13B | 16.6 | 62 | Compare |
|
PFE
Pfizer Inc.
|
$28.32
|
$154.70B | 21.0 | 68 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.89
|
$121.27B | 20.5 | 64 | Compare |
More NGNE Analysis
Data updated: Apr 02, 2026 | Industry: PHARMACEUTICAL PREPARATIONS (SIC 2834)
553 stocks in this industry